Van Leeuwen & Company’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-52,928
Closed -$5.79M 63
2020
Q4
$5.79M Sell
52,928
-4
-0% -$435 3.88% 5
2020
Q3
$5.76M Buy
52,932
+18,814
+55% +$1.91M 4.48% 3
2020
Q2
$3.12M Sell
34,118
-17,630
-34% -$1.59M 2.42% 13
2020
Q1
$4.08M Sell
51,748
-3,636
-7% -$303K 3.92% 4
2019
Q4
$4.81M Sell
55,384
-122
-0.2% -$10.2K 4.01% 2
2019
Q3
$4.64M Sell
55,506
-772
-1% -$65.6K 4.38% 2
2019
Q2
$4.73M Sell
56,278
-2,620
-4% -$206K 4.24% 2
2019
Q1
$4.71M Sell
58,898
-1,434
-2% -$107K 4.41% 2
2018
Q4
$4.36M Buy
60,332
+22,791
+61% +$1.6M 4.36% 2
2018
Q3
$2.75M Buy
+37,541
New +$2.46M 2.54% 9

Other funds holding ABT

Van Leeuwen & Company's ABT Position: Q1 2021 in Review

Van Leeuwen & Company sold out of Abbott (ABT) in Q1 2021, closing a stake of 52,928 shares — an estimated $5.79M sold.

Van Leeuwen & Company first reported a position in ABT in Q3 2018 and held it in 10 quarters. The position peaked at $5.79M in Q4 2020. 2,524 funds tracked by Wall St. Rank hold ABT as of Q1 2021.

  • Van Leeuwen & Company reported no remaining Abbott position as of Q1 2021 after selling out during the quarter.
  • Van Leeuwen & Company sold 52,928 Abbott shares in Q1 2021, an estimated $5.79M.
  • Van Leeuwen & Company first reported a position in Abbott in Q3 2018 and held it in 10 quarters.
  • Van Leeuwen & Company's Abbott position peaked at $5.79M in Q4 2020.
  • 2,524 funds tracked by Wall St. Rank held Abbott as of Q1 2021.

Based on Van Leeuwen & Company's 13F filing for Q1 2021, filed 11 May 2021.